Table 6.
Entire sample (N=250) |
Clusters |
|||
---|---|---|---|---|
High A and CF | Medium A and high CF | Low A and CF | ||
PVAS |
52.5 (16.9) |
55.5 (16.4) |
51.3 (17.1) |
50.0 (16.7) |
FIQ |
58.1 (15.0) |
66.6 (12.2)* |
58.1 (12.8)* |
47.3 (13.4)* |
HADS-anx |
10.8 (5.0) |
13.4 (4.1)* |
10.7 (4.6)* |
7.5 (4.3)* |
HADS-dep |
7.7 (4.7) |
10.8 (4.1)* |
7.7 (3.7)* |
3.8 (3.1)* |
PCS |
24.3 (13.6) |
33.2 (12.1)* |
24.0 (11.1)* |
13.8 (9.4)* |
CPAQ |
47.6 (23.4) |
30.9 (14.5)* |
45.5 (16.7)* |
69.7 (20.1)* |
MAAS | 3.7 (1.3) | 3.3 (1.1)* | 3.5 (1.0)* | 4.5 (0.96)* |
Note: PVAS, Pain Visual Analogue Scale; FIQ, Fibromyalgia Impact Questionnaire; HADS-anx, Anxiety; HADS-dep, Depression; PCS, Pain Catastrophizing Scale; CPAQ, Chronic Pain Acceptance Questionnaire ; MAAS, Mindful Attention Awareness Scale.
*Significant differences at p< .007.